Welcome to our dedicated page for Avantor news (Ticker: AVTR), a resource for investors and traders seeking the latest updates and insights on Avantor stock.
Avantor, Inc. (NYSE: AVTR) is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. This news page aggregates company announcements, earnings updates and other disclosures so readers can follow how Avantor’s operations, portfolio and governance evolve over time.
Recent news releases describe Avantor’s participation in investor conferences, quarterly earnings reports, leadership and board appointments, and product and service developments. Examples include announcements about the timing of quarterly and full-year earnings releases and related conference calls, as well as participation in events such as the J.P. Morgan Healthcare Conference. These items provide context on how the company communicates with the investment community and presents its financial performance.
Product- and operations-focused news highlights areas such as bioprocessing, biomanufacturing and laboratory services. Avantor has reported the launch of a sterile sampling platform and PUPSIT assemblies for bioprocessing, the development of a biodegradable viral inactivation detergent recognized with an Edison Patent Award, and the expansion of its Centralized Service Center model with a facility serving the Greater Boston area. These updates illustrate how the company positions its tools and services within scientific and industrial workflows.
Corporate governance news includes the appointment of new directors and senior executives, such as additions to the Board of Directors and the creation of an Executive Vice President and Chief Operating Officer role. Together, these news items offer insight into Avantor’s strategic priorities, leadership changes and ongoing initiatives. Investors, analysts and industry participants can use this page to monitor company communications and official announcements over time.
Avantor, a global provider of critical products and services in life sciences, announced the initiation of a private offering of euro-denominated senior first lien notes. These notes will be issued by its subsidiary, Avantor Funding, Inc., and guaranteed by its parent company and subsidiaries. The proceeds will be utilized to redeem existing senior notes due in 2024 and cover related expenses. The offering relies on exemptions from registration under the Securities Act, aimed at qualified institutional buyers. Avantor emphasizes its significant role within multiple industries and its extensive global reach.
Avantor, Inc. (AVTR) reported third-quarter 2020 net sales of $1.605 billion, up 6.7% year-over-year, with organic growth of 5.4%. However, the company faced a net loss of $42.2 million due to a $226.4 million debt extinguishment. Adjusted EBITDA increased 14% to $285.6 million, with a margin expansion of 112 basis points. Year-to-date cash flow from operations reached $623.8 million, a 134% rise. The conference call is scheduled for October 28, 2020, to discuss these results further.
Avantor, Inc. (NYSE: AVTR) reported preliminary unaudited revenues for Q3 2020, with total revenues of $1.60 billion, reflecting a 6.7% increase and 5.4% organic growth. The results indicate strong performance, particularly in the biopharma and healthcare markets. The company will release full financial results on October 28, 2020. It is important to note that these figures are preliminary and unaudited, pending final review.
Avantor, a leading global provider in life sciences and advanced technologies, has announced a quarterly cash dividend of $0.78 per share for its 6.250% Series A Mandatory Convertible Preferred Stock. This equates to a yield of 1.560% and will be payable on November 15, 2020, to shareholders recorded by November 1, 2020. This decision reflects Avantor's commitment to providing returns to its stakeholders while maintaining a strong position within the industry.
Avantor (NYSE: AVTR) announced that its General Counsel, Justin Miller, has been honored as a 'Legend In Law' by The Burton Awards Program, recognizing his outstanding legal achievements. He is one of 13 honorees this year, acknowledged for his exceptional reputation and contributions to the legal profession. Miller's career highlights include a significant federal case win at age 26 and leading Avantor's initial public offering in May 2019. The awards celebrate leaders who tackle complex legal challenges on a national and global scale.
Avantor, a global provider of mission-critical products and services, is set to release its third quarter 2020 financial results on October 28, 2020, after market close. A conference call will take place at 5:00 p.m. EDT the same day to discuss the results. Investors can join the call by dialing (866) 211-4132 domestically or (647) 689-6615 internationally, using access code 3557106. The earnings press release and related slides will be available on their website. A replay will be accessible until November 12, 2020.
Avantor has appointed Frederic Vanderhaegen as Executive Vice President for the Americas and Europe, effective immediately. He expands his role to include the Americas, enhancing the company's focus on customer research and development. This strategic move aims to improve customer service and innovation in the company’s offerings. Vanderhaegen, who joined Avantor in 2018, brings extensive leadership experience in the life sciences sector.
Avantor, a global leader in mission-critical products and services, will participate in the Morgan Stanley Virtual Healthcare Conference on September 16, 2020. CEO Michael Stubblefield is scheduled to present at 8:45 a.m. ET. Investors can access a live webcast through Avantor's investor relations page, which will remain available for replay until September 30, 2020. Avantor serves over 225,000 customers across various sectors, including biopharma and healthcare.
Avantor, a leading global provider of critical products and services, will participate in the 2020 Wells Fargo Virtual Healthcare Conference on September 10, 2020. President and CEO Michael Stubblefield will represent the company at approximately 10:00 a.m. Eastern Time. A live webcast will be available through Avantor's investor relations section and can be replayed until September 24, 2020. Avantor serves over 225,000 customer locations globally, supporting the biopharma, healthcare, education, and technology sectors.
Avantor, Inc. (NYSE: AVTR) announced the pricing of an upsized secondary offering by certain stockholders, including New Mountain Capital. A total of 55,555,555 shares of common stock will be sold for gross proceeds of approximately $1.1 billion. This is an increase from the originally proposed 38,500,000 shares. The offering will close on August 21, 2020, pending customary conditions. The underwriters have an option to purchase an additional 8,333,333 shares. The company itself is not selling any shares and will not receive any proceeds from this offering.